Le traitement des métastases osseuses par radiopharmaceutiques à tropisme osseux;Bone metastases treated with radiopharmaceuticals

Bulletin du Cancer

Volumn 100, Issue 11, 2013, Pages 1223-1227

  Giammarile, Francesco ^a  

^a UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

Author keywords

Bone pain palliation; Hyperalgic bone metastases; Radiometabolic therapy

Indexed keywords

LEXIDRONAM SAMARIUM SM 153; RADIOPHARMACEUTICAL AGENT; RADIUM CHLORIDE RA 223; STRONTIUM 89; ANALGESIC AGENT; ORGANOMETALLIC COMPOUND; ORGANOPHOSPHORUS COMPOUND; RADIUM; SAMARIUM ETHYLENEDIAMINETETRAMETHYLENEPHOSPHONATE; STRONTIUM; STRONTIUM CHLORIDE;

BONE METASTASIS; BONE PAIN; CANCER PATIENT; EXTERNAL BEAM RADIOTHERAPY; PROSTATE CANCER; REVIEW; BONE TUMOR; BREAST TUMOR; FEMALE; HUMAN; MALE; METASTASIS; PAIN; PATHOLOGY; PROSTATE TUMOR;

ANALGESICS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RADIUM; STRONTIUM; STRONTIUM RADIOISOTOPES;

EID: 84889023177     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2013.1842     Document Type: Article

References (2)

1. Robinson RG. Strontium-89-precursor targeted therapy for pain relief of blastic metastatic disease. Cancer 1993 ; 72 : 3433-5.
2. Serafini AN, Houston SJ, Resche I, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebocontrolled clinical trial. J Clin Oncol 1998 ; 16 : 1574-81.